Surgical treatment for oligoprogression in metastasized renal cell carcinoma after medical treatment

• Conditions: C64; C78.0; Malignant neoplasm of kidney, except renal pelvis; Secondary malignant neoplasm of lung

• Registration Number: DRKS00025088
• Lead Sponsor: niversitätsklinikum Freiburg Klinik für Thoraxchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients with oligoprogressive metastatic renal cell carcinoma after drug therapy
- Surgical resection of one or more thoracic metastases at the Clinic for Thoracic Surgery, Freiburg, Germany

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Survival

Secondary Outcome Measures

Name	Time	Method
progression free survival, disease free survival, surgery related mortality and morbidity, duration of hospital stay